For more information, availability and pricing options for sponsorship/exhibition opportunities at the event, please contact Jon Liong at email@example.com.
Updated on 05-22-2013
Quintiles is the only fully integrated biopharmaceutical services provider offering clini- cal, commercial, consulting and capital solutions worldwide. We help customers manage change, navigate risk and seize opportunities in the new health landscape. Quintiles’ more than 24,000 talented and engaged employees in nearly 60 countries deliver on promises to customers every day, working with an unwavering commitment to patients, safety and ethics. As a pioneer in biopharmaceutical services, Quintiles has helped de- velop or commercialize all of the top 50 best-selling drugs. Quintiles is consistently cited as one of the most favored contract research organizations (CRO) in independent sur- veys of the biopharma industry.
Fountain Medical Development
Fountain Medical Development Ltd. is a contract research organization (CRO) offering a full range of ICH GCP compliant clinical research services in China and East Asia. The FMD management team has decades of combined experience working with the world’s leading CROs and drug developers. In the Chinese CRO market, we fill the void of a service provider that balance high quality with moderate cost. Our extensive global experience in multiple therapeutic areas is unmatched by other local CROs, and our lower operational cost allows us to pass significant savings on to our clients. Fountain has completed more than 100 clinical trial projects, we have been in good partnership with more than 200 sites in Asia and we have enrolled more than 7000 patients in clinical trials. Fountain’s success includes undertaking pivotal international studies. Fountain is your trustworthy CRO Choice in Asia.
Boon Pharmaceutical Research
Boon Pharmaceutical Research, Ltd. is a Biometrics specialty Clinical Research Organization with capabilities covering all aspects of Biometrics-related fields in a clinical R&D: Data Management and Technology, Scientific Programming and Biostatistics, and Medical Writing. Boon EDC, Boon IWRS/IVRS, and Boon CDMS are Boon’s proprietary properties for Electronic Data Capture; for centralized randomization, and for drug distribution, tracking and inventory management; and for paper clinical data management. They have been used both in China and the US for phase I-IV, NIS, PMS clinical trials and national 12.5 programs with successful tracking records.
As a leading commercial clinical laboratory in China, KingMed is accredited by CAP (13 disciplines), ISO15189, ISO/IEC17025, ISO9001, NGSP Level 1 Laboratory, and follows GLP, US 21 CFR Part 11, ICH-GCP and other applicable laws and regulations. We provide comprehensive laboratory services including clinical diagnostic tests, clinical trial central laboratory service, medical research and development center, and food & hygiene tests. With its remarkable degree of advanced technology and research capabilities, KingMed is currently able to provide nearly 1,700 clinical test items, ranging from regular tests to esoteric tests. Through our nationwide network of 19 primary laboratories located in the provincial capital cities, KingMed provides diagnostic tests and information services for clinics, hospitals, international pharmaceutical companies, CROs and biotech companies.
MicroConstants China is a full service early stage clinical trial CRO with in-house CNAS and OECD GLP certified bioanalytical lab in Beijing. Our mission is to conduct preclinical and clinical services in China to meet pharmaceutical product registration requirement in China and abroad. Working closely with ICH/SFDA GCP compliant clinical partners in China, we offer Phase I/II, BE, PK, drug/food interaction clinical trial as well as preclinical and clinical PK sample bioanalysis services. With FDA GCP/GLP compliant bioanalytical labs in both China and U.S., MicroConstants is in a great position to meet the growing demand of pharmaceutical outsourcing to Asia by eliminating the trouble of clinical sample shipping to/from China.
Hangzhou Tigermed Consulting is a leading Contract Research Organization (CRO) in China dedicated to providing regulatory affairs, Phase I-IV clinical trials, data manage- ment, biostatistics, medical writing, medical translation and GCP training services for healthcare products. Since inception in 2004, Tigermed has been committed to accel- erating your product development timeline while reducing R&D costs and risks, helping you to bring the miracles of your new product to market effectively. Headquartered in Hangzhou, Tigermed operates 7 subsidiaries, 40 offices in China mainland. With more than 620 staff, Tigermed has set up global Standard Operating Procedures (SOPs) and successfully serviced more than 300 local and global clients in the conduct of hundreds of regulatory affairs, clinical trials, data management and biostatistics projects.